Cuba vs Oman: The number of people with susceptibility test result for rifampicin
Cuba
133
in 2021
Oman
144
in 2021
Cuba rank
104th
Oman rank
102nd
The number of people with susceptibility test result for rifampicin over time
- Cuba
- Oman
How they compare
Oman currently reports 144 against 133 in Cuba, a difference of 11.
That makes Oman's figure about 1.1 times Cuba's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Cuba ahead.
Cuba ranks 104th and Oman ranks 102nd of 155 countries.
Across the 2 decades both report, Cuba averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Cuba | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 316.33 | 220.67 | 95.67 | Cuba |
| 2020s | 161.5 | 181 | 19.5 | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cuba or Oman?
- Oman, at 144 against 133 in Cuba as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cuba and Oman?
- 11, with Oman ahead.
- How many years of comparable data are there for Cuba and Oman?
- 5 years are reported by both, from 2017 to 2021.
- How do Cuba and Oman rank globally for the number of people with susceptibility test result for rifampicin?
- Cuba ranks 104th and Oman ranks 102nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.